Lakefront Biotherapeutics repurchases 125,517 shares; treasury 1,418,855
Lakefront Biotherapeutics NV repurchased 125,517 shares between Sep 7–11, 2026 under its program. As of Sep 11 close, it held 1,418,855 of its own ordinary shares.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.